S. Nyarko

Preclinical Immuno-recognition and Neutralization of Lethality Assessment of a New Polyvalent Antivenom, VINS Snake Venom Antiserum – African IHS®, against Envenomation of Ten African Viperid and Elapid Snakes

S. Adjei, Samuel B. Nyarko, G. Djameh, 2021 .

The Diversity, Multiplicity of Infection and Population Structure of P. falciparum Parasites Circulating in Asymptomatic Carriers Living in High and Low Malaria Transmission Settings of Ghana

L. Amoah, S. P. Salifu, E. Lo, 2019, Genes.

Apolipoprotein E genetic variation, atherogenic index and cardiovascular disease risk assessment in an African population: An analysis of HIV and malaria patients in Ghana

N. E. Thomford, M. Ekor, G. Kyei, 2023, PloS one.

Targeting the Plasmodium falciparum’s Thymidylate Monophosphate Kinase for the Identification of Novel Antimalarial Natural Compounds

S. Kwofie, A. Ghansah, M. Wilson, 2022, Frontiers in Cellular and Infection Microbiology.

A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential ‘culprit’ for the tramadol ‘abuse crisis’

N. E. Thomford, S. A. Abraham, S. Nyarko, 2024, BMC medical genomics.

An exploratory pharmacogenetic screening of SLC22A6, SLC22A8, ABCC4 and ABCC10 genes in a cohort of Ghanaian HBV patients

N. E. Thomford, P. Nsiah, A. Anyanful, 2023, Egyptian Journal of Medical Human Genetics.